LIN Earnings— Revenue, EPS & Growth
Real earnings data for Linde plc (LIN) filed with the U.S. Securities and Exchange Commission. These are actual reported numbers from SEC EDGAR filings — not analyst estimates or projections.
Most recent quarter ended: June 30, 2026
Quarterly Revenue
$9.3B
▲ +9.3% YoY
Net Income
$1.9B
20.8% margin
Diluted EPS
$4.15
YoY Revenue Growth
+9.3%
LIN Revenue Trend — Last 5 Quarters
Quarterly revenue progression for Linde plc. The most recent quarter is highlighted.
Understanding LIN Earnings
Linde plc reported quarterly revenue of $9.3B — a +9.3% change compared to the same quarter last year. The company achieved a net profit margin of 20.8%, translating to net income of $1.9B. On a per-share basis, diluted earnings came in at $4.15.
Revenue growth is one of the most important metrics for evaluating LIN. The company is growing at a moderate pace, typical for a mature technology company.
To see how these fundamentals factor into our AI's directional outlook, visit the LIN forecast page.
Get notified before LIN reports earnings
Free alerts 3 days before earnings + AI positioning advice (hold through, trim, or buy the dip after).
LIN Earnings — FAQ
What was LIN's most recent EPS?
Linde plc reported diluted EPS of $4.15 for the quarter ending June 30, 2026. This is the actual filed number from the SEC — not an estimate.
Is LIN revenue growing?
Linde plc revenue grew 9.3% year-over-year in the most recent quarter. Quarterly revenue was $9.3B.
When does LIN report earnings next?
Most companies report quarterly earnings approximately 4-6 weeks after their fiscal quarter ends. Sign up for our free earnings alerts to get notified 3 days before LIN reports.
Where does this earnings data come from?
All earnings data on this page is sourced directly from U.S. SEC EDGAR filings (XBRL format). These are the actual numbers reported by Linde plc to the Securities and Exchange Commission — not analyst estimates or third-party calculations.
Source: U.S. SEC EDGAR. Educational research only. Not investment advice.